Showing results (11-20 of 323) with videos related to
Sort By:
Pageof 33
Gynecologic Oncology|April 1, 1996
The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancerH Gogas, F Shapiro, C Aghajanian, et al.Gynecologic Oncology|March 30, 2001
Complications associated with intraperitoneal chemotherapy cathetersS Makhija, M Leitao, P Sabbatini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancerM Markman, T Hakes, B Reichman, et al.Gynecologic Oncology|November 5, 1997
High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-upF Shapiro, J Schneider, M Markman, et al.Archives of Facial Plastic Surgery|October 3, 2009
Improved skin paddle survival in pectoralis major myocutaneous flap reconstruction of head and neck defectsVijay R Ramakrishnan, William Yao, John P CampanaJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsyR R Barakat, T A Gilewski, L Almadrones, et al.Forensic Science|December 1, 1975
[Pulmonary lesions observed in victims of an aircraft accident]M Durigon, J P Campana, E Eliakis, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1991
Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancerM Markmann, R Rothman, B Reichman, et al.Gynecologic Oncology|June 11, 1991
Late effects of cisplatin-based chemotherapy on renal function in patients with ovarian carcinomaM Markman, R Rothman, T Hakes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 1991
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatinM Markman, R Rothman, T Hakes, et al.Pageof 33